NRXN3 and breast carcinoma: NRXN3 functions in the vertebrate nervous system as cell adhesion molecules and receptors and was previously found to be mutated in colon cancer [12], breast cancer [10], glioma [33], squamous cell carcinoma of the head and neck [34], [35] and ovary cancer [15].